Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Bio-Rad Laboratories, Inc. (BIO.B) Stock-Based Compensation data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$651.60M |
|
$317.80M |
|
$306.30M |
|
$345.30M |
|
$574.50M |
|
$77.10M |
|
$336.90M |
|
$414.00M |
|
$79.60M |
|
$317.80M |
|
$317.80M |
|
$317.80M |
|
$-94.30M |
|
$77.10M |
|
$77.10M |
|
27.23M |
|
27.23M |
|
$11.67 |
|
$11.67 |
|
| Balance Sheet Financials | |
$2.81B |
|
$549.70M |
|
$7.40B |
|
$10.21B |
|
$548.90M |
|
$1.20B |
|
$2.54B |
|
$3.09B |
|
$7.13B |
|
$6.15B |
|
$7.13B |
|
27.06M |
|
| Cash Flow Statement Financials | |
$246.40M |
|
$-112.50M |
|
$-234.00M |
|
$489.80M |
|
$371.70M |
|
$-118.10M |
|
|
Stock-Based Compensation |
-- |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.12 |
|
-- |
|
-- |
|
0.14 |
|
0.17 |
|
52.99% |
|
11.83% |
|
11.83% |
|
-- |
|
63.54% |
|
48.77% |
|
$166.40M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
0.38 |
|
1.39 |
|
64.90 |
|
4.46% |
|
5.17% |
|
3.11% |
|
3.82% |
|
$263.42 |
|
$6.11 |
|
$9.05 |
|